Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.

Q2 2025 Earnings Call February 4, 2025 8:00 AM ETCompany ParticipantsBen Krasinski - Senior Director, IRMichael J.

Q4 2024 Earnings Call Transcript February 5, 2025 CSG Systems International, Inc. beats earnings expectations. Reported EPS is $1.65, expectations were $1.2. Operator: Thank you for standing by. My ...

Reports Q4 revenue $9.7B, consensus $9.44B. “2024 was a remarkable year for PMI. We delivered very strong full-year results driven by the ...

Reports Q4 revenue $521M, consensus $518.54M. The company said, “Our solid sales growth in the second half of 2024 mirrors our plans for ...

The Food and Drug Administration announced it would decide by April 2024 whether chemical hair straightening products sold in the U.S. would be banned from using formaldehyde or ingredients that ...

Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced its full year and Q4 2024 financial results. Søren ...

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Here's a look at the details from the report: Erica Kollmann Ardelyx Files Lawsuit Over Medicare Drug Payment Rules, Claims It Will Limit Patient Access To Kidney Disease Treatment Ardelyx ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Melissa Gilbert Says 'Little House On The Prairie' Reboot At Netflix "Will Do Things We Didn't Get To Do So Easily In '70s" ...